Fidelity Investments’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Buy |
191,833
+27,963
| +17% | +$180K | ﹤0.01% | 2803 |
|
|
2025
Q4 | $975K | Buy |
163,870
+18,585
| +13% | +$98.7K | ﹤0.01% | 2856 |
|
|
2025
Q3 | $771K | Buy |
145,285
+12,921
| +10% | +$54.8K | ﹤0.01% | 2892 |
|
|
2025
Q2 | $454K | Buy |
132,364
+5,190
| +4% | +$16.6K | ﹤0.01% | 2996 |
|
|
2025
Q1 | $376K | Sell |
127,174
-4,676
| -4% | -$14.6K | ﹤0.01% | 3001 |
|
|
2024
Q4 | $402K | Buy |
131,850
+13,585
| +11% | +$39.5K | ﹤0.01% | 3007 |
|
|
2024
Q3 | $302K | Buy |
118,265
+25,183
| +27% | +$76.2K | ﹤0.01% | 3054 |
|
|
2024
Q2 | $303K | Buy |
93,082
+1,392
| +2% | +$6.11K | ﹤0.01% | 2900 |
|
|
2024
Q1 | $486K | Buy |
91,690
+35,616
| +64% | +$192K | ﹤0.01% | 2730 |
|
|
2023
Q4 | $243K | Sell |
56,074
-8,305
| -13% | -$27.5K | ﹤0.01% | 2903 |
|
|
2023
Q3 | $169K | Buy |
64,379
+461
| +0.7% | +$1.57K | ﹤0.01% | 2937 |
|
|
2023
Q2 | $226K | Sell |
63,918
-3
| -0% | -$9 | ﹤0.01% | 2911 |
|
|
2023
Q1 | $198K | Buy |
63,921
+12
| +0% | +$45 | ﹤0.01% | 2988 |
|
|
2022
Q4 | $270K | Sell |
63,909
-402
| -0.6% | -$1.39K | ﹤0.01% | 2913 |
|
|
2022
Q3 | $152K | Sell |
64,311
-434
| -0.7% | -$1.27K | ﹤0.01% | 3136 |
|
|
2022
Q2 | $184K | Buy |
64,745
+53
| +0.1% | +$132 | ﹤0.01% | 3147 |
|
|
2022
Q1 | $186K | Buy |
+64,692
| New | +$167K | ﹤0.01% | 3270 |
|
|
2020
Q4 | – | Sell |
-12,768
| Closed | -$129K | – | 4176 |
|
|
2020
Q3 | $129K | Sell |
12,768
-36,600
| -74% | -$373K | ﹤0.01% | 2752 |
|
|
2020
Q2 | $515K | Sell |
49,368
-73,500
| -60% | -$761K | ﹤0.01% | 2506 |
|
|
2020
Q1 | $1.04M | Hold |
122,868
| – | – | ﹤0.01% | 2322 |
|
|
2019
Q4 | $1.07M | Sell |
122,868
-91,700
| -43% | -$759K | ﹤0.01% | 2388 |
|
|
2019
Q3 | $2.31M | Sell |
214,568
-74,213
| -26% | -$801K | ﹤0.01% | 2237 |
|
|
2019
Q2 | $3.67M | Sell |
288,781
-238,287
| -45% | -$5.49M | ﹤0.01% | 2182 |
|
|
2019
Q1 | $20.4M | Sell |
527,068
-333,198
| -39% | -$10.2M | ﹤0.01% | 1602 |
|
|
2018
Q4 | $17.5M | Sell |
860,266
-521,627
| -38% | -$15.7M | ﹤0.01% | 1610 |
|
|
2018
Q3 | $63.4M | Sell |
1,381,893
-338,401
| -20% | -$16.3M | 0.01% | 1149 |
|
|
2018
Q2 | $102M | Buy |
1,720,294
+132,205
| +8% | +$7.66M | 0.01% | 947 |
|
|
2018
Q1 | $108M | Sell |
1,588,089
-120,065
| -7% | -$8.99M | 0.01% | 952 |
|
|
2017
Q4 | $169M | Sell |
1,708,154
-405,816
| -19% | -$45.4M | 0.02% | 762 |
|
|
2017
Q3 | $253M | Sell |
2,113,970
-406,078
| -16% | -$37.8M | 0.03% | 588 |
|
|
2017
Q2 | $220M | Sell |
2,520,048
-1,020,681
| -29% | -$57.1M | 0.03% | 653 |
|
|
2017
Q1 | $132M | Buy |
3,540,729
+81,410
| +2% | +$2.97M | 0.02% | 872 |
|
|
2016
Q4 | $106M | Sell |
3,459,319
-1,414,644
| -29% | -$61.2M | 0.01% | 962 |
|
|
2016
Q3 | $327M | Hold |
4,873,963
| – | – | 0.04% | 467 |
|
|
2016
Q2 | $145M | Buy |
4,873,963
+937
| +0% | +$29.3K | 0.02% | 803 |
|
|
2016
Q1 | $143M | Buy |
4,873,026
+7,664
| +0.2% | +$346K | 0.02% | 814 |
|
|
2015
Q4 | $381M | Buy |
4,865,362
+18,789
| +0.4% | +$1.47M | 0.05% | 397 |
|
|
2015
Q3 | $365M | Buy |
4,846,573
+23,949
| +0.5% | +$2.26M | 0.05% | 397 |
|
|
2015
Q2 | $563M | Buy |
4,822,624
+796,826
| +20% | +$144M | 0.07% | 300 |
|
|
2015
Q1 | $951M | Sell |
4,025,798
-9,638
| -0.2% | -$2.06M | 0.12% | 176 |
|
|
2014
Q4 | $764M | Buy |
4,035,436
+1,245,921
| +45% | +$276M | 0.1% | 220 |
|
|
2014
Q3 | $665M | Buy |
2,789,515
+1,270,897
| +84% | +$261M | 0.09% | 254 |
|
|
2014
Q2 | $100M | Sell |
1,518,618
-774,467
| -34% | -$55.1M | 0.01% | 1001 |
|
|
2014
Q1 | $239M | Sell |
2,293,085
-574,538
| -20% | -$67.5M | 0.03% | 571 |
|
|
2013
Q4 | $297M | Sell |
2,867,623
-729,374
| -20% | -$42.8M | 0.04% | 459 |
|
|
2013
Q3 | $193M | Sell |
3,596,997
-14,800
| -0.4% | -$798K | 0.03% | 633 |
|
|
2013
Q2 | $160M | Buy |
+3,611,797
| New | +$127M | 0.03% | 679 |
|
Other funds holding PBYI
ACA
VCM
VPM
Fidelity Investments's PBYI Position: Q1 2026 in Review
Fidelity Investments increased its Puma Biotechnology (PBYI) stake by 17% in Q1 2026, buying an estimated $180K and bringing the position to 191,833 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2803.
Fidelity Investments first reported a position in PBYI in Q2 2013 and has held it in 47 quarters since. The position peaked at $951M in Q1 2015. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.
- Fidelity Investments held 191,833 shares of Puma Biotechnology worth $1.23M as of Q1 2026.
- Fidelity Investments bought 27,963 Puma Biotechnology shares in Q1 2026, an estimated $180K.
- Puma Biotechnology made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2803 holding.
- Fidelity Investments first reported a position in Puma Biotechnology in Q2 2013 and has held it in 47 quarters since.
- Fidelity Investments's Puma Biotechnology position peaked at $951M in Q1 2015.
- 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.